Batch checker

Check a Kerala Medical Services Corporation Ltd batch number

17 batches by Kerala Medical Services Corporation Ltd have been declared Not of Standard Quality in CDSCO or state-lab alerts. Type your batch number to check it, or scan the full list below. Full manufacturer record

All 17 flagged batches, Kerala Medical Services Corporation Ltd
Product Batch Reason declared NSQ Tested by Alert
Vitamin B Complex Tablets N.F.I S0018/2 4-25Mfg ? · Exp ? The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol.Other DTL ThiruvananthapuramState lab Feb 2025
Vitamin B Complex Tablets N.F.I S0017/2 4-25Mfg ? · Exp ? The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol.Other DTL ThiruvananthapuramState lab Feb 2025
Clopidogrel Tab IP 75 mg D 2720/24 -25Mfg ? · Exp ? It fails the test ?Dissolution?, ?Assay? and descriptive part for tablets specified above as per IPAssay DTL ThiruvananthapuramState lab Feb 2025
Cefixime Oral Suspension IP 100 mg/5ml D2852/2 4-25Mfg ? · Exp ? It fails the test ?Assay? and ?Descriptive part? for oral powders specified above as per IPAssay DTL ThiruvananthapuramState lab Feb 2025
Vitamin B Complex Tablets NFI S0016/24 -25Mfg ? · Exp ? The sample does not conform to IP standards with respect to ?Descriptive Part? for tablets.Other DTL ThiruvananthapuramState lab Jan 2025
Losartan Potassium Tab IP 25 mg D 2615/24- 25Mfg ? · Exp ? It fails the ?Descriptive Part? for the tablets as per IP , tablets should have sufficient hardness for handling without crumbling and breakingOther DTL ThiruvananthapuramState lab Jan 2025
Glimepiride Tablet IP 1 mg D2721/24 -25Mfg ? · Exp ? The sample does not conform to IP standards with respect to ?Descriptive Part? for tablets.Other DTL ThiruvananthapuramState lab Jan 2025
Glimepiride Tablet IP 1 mg D2505/24 -25Mfg ? · Exp ? It fails the test dissolution and ?Descriptive Part? specified in the Laboratory Protocol as per IPDissolution DTL ThiruvananthapuramState lab Jan 2025
Glimepiride Tablet IP D2854/24 -25Mfg ? · Exp ? The sample does not conform to IP standards with respect to ?Descriptive Part? for tablets.Other DTL ThiruvananthapuramState lab Jan 2025
Paracetamol Tab IP 500 mg. D2370/24- 25Mfg ? · Exp ? It fails the test ?Dissolution? as per IPDissolution DTL ThiruvananthapuramState lab Dec 2024
Metformin Hydrochloride Sustained Release Tab IP 500 mg D2164/24-25Mfg ? · Exp ? It fails the test microbial contamination in Non-sterile products and Descriptive part for tablets as per IPMicrobial limits DTL ThiruvananthapuramState lab Dec 2024
Glimepiride Tab IP 1 mg D1885/24- 25Mfg ? · Exp ? Does not conform to IP standards with respect to descriptive partOther DTL ThiruvananthapuramState lab Nov 2024
Telmisartan Tab IP 40 mg D1153/24-25Mfg ? · Exp ? The sample does not conform to IP Standards with respective to ?Descriptive part? of tablets and further tests cannot be performed due to above reasons.Other DTL ThiruvananthapuramState lab Sep 2024
Pantoprazole Inj.BP 40 mg D 0923/24- 25Mfg ? · Exp ? It fails the test ?Sterility? specified in the laboratory protocol as per IPSterility DTL ThiruvananthapuramState lab Sep 2024
Glimepiride Tab IP D1272/24-25Mfg ? · Exp ? The sample fails the descriptive part for tablets as they are not sufficiently hard to withstand handling without crumbling or breaking and further tests cannot be performed due to above reasonOther DTL ThiruvananthapuramState lab Sep 2024
Cough Syrup D 1278/24- 25Mfg ? · Exp ? The sample fails the ?Descriptive part? for oral dosage forms of Schedule V of drugs and cosmetics Act and Rules, as the syrup contains red coloured suspended paticlesDescription DTL ThiruvananthapuramState lab Sep 2024
Pantoprazole Inj. BP 40 mg D0726/24- 25Mfg ? · Exp ? The sample does not comply with BP. It fails the test Particulate contaminatio n clarity and colour of solution.Particulate matter DTL ThiruvananthapuramState lab Aug 2024

Data: CDSCO NSQ portal, Jan 2019, Jul 2026. Absence from the list is not proof of quality.